EXACT Therapeutics to host virtual company presentation on December 4, 2024 following the announcement of completion of private placement

03 Dec 2024 08:21 CET

Oslo, Norway; December 03, 2024. EXACT Therapeutics (Euronext Growth: EXTX)
today announced it will webcast a company presentation following the successful
private placement of 145 MNOK with GE Healthcare as cornerstone investor. The
presentation will be followed by a Q&A session.

Webcast details:
Date: Wednesday December 4, 2024
Time: 2 p.m. CET / 8 a.m. ET
Webcast: https://channel.royalcast.com/landingpage/hegnarmedia/20241204_2/

An archived version of the presentation will be available in the Investors
section of the Company’s website:

https://exact-tx.com/finreports

About EXACT Therapeutics:

EXACT Therapeutics is a clinical-stage precision medicine company utilizing the
power of ultrasound and microbubbles to enable targeted drug delivery in
oncology. Acoustic Cluster Therapy (ACT®) follows a unique approach and may be
applied to a wide range of therapeutic agents within oncology and across a
multitude of other indications including brain diseases. www.exact-tx.com

For further information, please contact:
Per Walday
CEO EXACT Therapeutics
Email: per.walday@exact-tx.com

More information:
Access the news on Oslo Bors NewsWeb site